Cyndeo Wealth Partners, LLC Invitae Corp Transaction History

Cyndeo Wealth Partners, LLC

  • $1.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023
BUY
$0.6 - $1.53 $1,866 - $4,759
3,111 Added 6.8%
48,865 $29,000
Q2 2023

Jul 27, 2023
BUY
$1.05 - $1.63 $10,426 - $16,185
9,930 Added 27.72%
45,754 $51,000
Q1 2023

Apr 21, 2023
BUY
$1.2 - $2.73 $2,287 - $5,203
1,906 Added 5.62%
35,824 $48,000
Q4 2022

Jan 25, 2023
BUY
$1.71 - $3.61 $57,999 - $122,443
33,918 New
33,918 $0

Others Institutions Holding NVTA

# of Institutions
21
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Cyndeo Wealth Partners, LLC Portfolio

Follow Cyndeo Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cyndeo Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cyndeo Wealth Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email